# US 8,278,112 B2 · Site-specific installation of methyl-lysine analogues into recombinant histones

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 8,278,112 B2
- Document ID: US8278112B2
- Status: Granted
- Kind: B2
- Application number: 11/961,956
- Filed: 2007-12-20
- Published: 2008-08-21
- Granted: 2012-10-02
- Earliest claimed: 2006-12-21
- Assignees: The Regents of the University of California
- Inventors: Kevan Shokat; Matthew D. Simon
- Web page: https://patentgrep.com/patent/US8278112B2

## CPC

- C07K 1/1075: {by covalent attachment of amino acids or peptide residues}
- C07K 14/4702: {Regulators; Modulating activity}
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)

## Abstract

The present invention provides reagents and methods for the introduction of analogues of methyl or acetyl lysine into histone proteins.

## Claims

### Claim 1

A method of introducing a site specific mono-, di, or tri-methylated lysine residue analogue into a histone H3 or H4 protein comprising the steps of:
(a) mutating the cysteine residues in the native sequence of the histone protein to a different amino acid residue;
(b) mutating at least one lysine residue in the amino acid sequence of the histone protein to a cysteine residue to generate a cysteine containing protein; and
(c) contacting the cysteine containing protein with a compound of the structure: R—CH2CH2-NH(Me)x, wherein R is a leaving group and x is 1, 2, or 3, thereby introducing a site specific mono-, di, or tri-methylated lysine residue analogue into a histone protein.

### Claim 2 (depends on 1)

The method of claim 1, wherein the different amino acid residue is alanine.

### Claim 3 (depends on 1)

The method of claim 1, wherein R is a halide.

### Claim 4 (depends on 3)

The method of claim 3, wherein the halide is Cl, Br, or I.

### Claim 5 (depends on 1)

The method of claim 1, wherein R is mesylate or tosylate.

### Claim 6 (depends on 1)

The method of claim 1, wherein the specific lysine residue is K4, K9, K14, K27, K36, or K79 of histone H3.

### Claim 7 (depends on 1)

The method of claim 1, wherein the specific lysine residue is K5, KS, K12, K16, or K20 of histone H4.

### Claim 8 (depends on 1)

The method of claim 1, wherein the cysteine containing protein is treated with a reducing agent prior to step (c).

### Claim 9 (depends on 8)

The method of claim 8, wherein the reducing agent is DTT.

### Claim 10

An isolated histone H3 or H4 protein comprising a lysine to cysteine substitution, wherein the substituted cysteine comprises the side chain structure —S—CH2CH2-NH(Me)x, wherein x is 1, 2, or 3.

### Claim 11 (depends on 10)

The isolated histone protein of claim 10, wherein the lysine to cysteine substitution is K4C, K9C, K14C, K27C, K36C, or K79C of histone H3.

### Claim 12 (depends on 10)

The isolated histone protein of claim 10, wherein the lysine to cysteine substitution is K5C, K8C, K12C, K16C, or K20C of histone H4.

### Claim 13

An isolated histone H3 or H4 protein comprising site specific mono-, di, or tri-methylated lysine residue analogues derived by a process comprising the steps of:
(a) mutating the cysteine residues in the native sequence of the H3 histone protein to alanine;
(b) mutating at least one lysine residue in the sequence of the H3 protein to a cysteine residue to generate a cysteine containing protein; and
(c) contacting the cysteine containing protein with a compound of the structure: RCH2CH2-NH(Me)x, wherein R is a leaving group and x is 1, 2, or 3.

### Claim 14 (depends on 13)

The isolated histone protein of claim 13, wherein R is a halide.

### Claim 15 (depends on 14)

The isolated histone protein of claim 14, wherein the halide is Cl, Br, or I.

### Claim 16 (depends on 13)

The method of claim 13, wherein R is mesylate or tosylate.

### Claim 17 (depends on 13)

The isolated histone protein of claim 13, wherein the histone protein is histone H3 or H4.

### Claim 18 (depends on 13)

The isolated histone protein of claim 13, wherein the specific lysine residue is K4, K9, K14, K27, K36, or K79 of histone H3.

### Claim 19 (depends on 13)

The isolated histone protein of claim 13, wherein the specific lysine residue is K5, K8, K12, K16, or K20 of histone H4.

### Claim 20

A method for assaying the effect of methylation of at least one lysine residue on a histone protein on the histone H3 or H4 protein's activity comprising the steps of:
(a) mutating the cysteine residues in the native sequence of the histone H3 protein to alanine;
(b) mutating at least one lysine residue in the sequence of the histone protein to a cysteine residue to generate a cysteine containing histone protein;
(c) contacting the cysteine containing histone protein with a compound of the structure: R—CH2CH2-NH(Me)x, wherein R is a leaving group and x is 1, 2, or 3 to generate a methylated protein; and
(d) comparing the activity of the methylated histone protein with the histone protein without the mutation or with a protein derived after step (c) in which x is 0,
thereby assaying the effect of methylation of at least one lysine residue on the histone protein's activity.

### Claim 21 (depends on 20)

The method of claim 20, wherein the assaying comprises measuring octomer reconstitution.

### Claim 22 (depends on 20)

The method of claim 20, wherein the assaying comprises measuring nucleosome remodeling.

### Claim 23 (depends on 10)

The isolated histone protein of claim 10, wherein the histone protein further comprises substitution of the cysteine residues in the native sequence of the histone protein to a different amino acid residue.
